Polycystic ovarian syndrome and metabolic complications: Beyond the excess of androgens

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder, it affects mostly women of reproductive age and some studies have reported that up to 21[%] of women present this syndrome. There are different diagnostic criteria for PCOS that characterize these patients into one of various phenotypes. This disorder has great implications on women's health because it has been linked to other metabolic, endocrine and fertility disorders. Due to recent investigations, there has been a surge of new information about the pathogenesis of this disease, which in turn has helped explore new biochemical markers and pathophysiological mechanisms of PCOS and associated diseases, thus allowing a clearer identification and better management of these patients. This new information can lead to a breakthrough in the development of potential therapies and more effective diagnostic methods.